Skip to Main Content

Author Details

Nicole Pinto
School of Public Policy at the University of Calgary
2014
29
12
PMIDPaper TitleJournal TitlePublished Year
37944818Interprofessional Teamwork: A Qualitative Study on Adapting Central Policies to Local Conditions in a Labour and Delivery Unit.J Obstet Gynaecol Can2024
36528473Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.Urol Oncol2023
37460971Doing primary care integration: a qualitative study of meso-level collaborative practices.BMC Prim Care2023
35908827Considering context: Adaptive elements of a simulation program to improve primary care safety during the COVID-19 pandemic in Alberta, Canada.Am J Infect Control2022
35443974Improving Conversations With COVID-19 Vaccine Hesitant Patients: Action Research to Support Family Physicians.Ann Fam Med2022
33481807Rapid conversion of an in-patient hospital unit to accommodate COVID-19: An interdisciplinary human factors, ethnography, and infection prevention and control approach.PLoS One2021
34895409A "Shock Test" to Primary Care Integration: COVID-19 Lessons from Alberta.Healthc Policy2021
34422296Virtual tabletop simulations for primary care pandemic preparedness and response.BMJ Simul Technol Enhanc Learn2021
34475951Detection of Circulating Tumor DNA in Patients with Thyroid Nodules.Int J Endocrinol2021
32970704Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.PLoS One2020
31864959Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.Oral Oncol2020
31804024Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.Mol Oncol2020
33059733TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.J Exp Clin Cancer Res2020
33138054Determinants of Implementation of a Clinical Practice Guideline for Homeless Health.Int J Environ Res Public Health2020
30468243A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth.Int J Cancer2019
31844556Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.Cancers Head Neck2019
31887152Common trust and personal safety issues: A systematic review on the acceptability of health and social interventions for persons with lived experience of homelessness.PLoS One2019
31393061Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.Mol Oncol2019
30626742Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.JCI Insight2019
30419054Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.PLoS One2018
29899842High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.Oncotarget2018
30115483ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.Oral Oncol2018
29069723Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.Oncotarget2017
26281010Impact of Question Content on e-Consultation Outcomes.Telemed J E Health2016
26271341Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.Pathol Oncol Res2016
24359121Self-assembly enhances the strength of fibers made from vimentin intermediate filament proteins.Biomacromolecules2014
25038405The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses.Virus Res2014
25276134Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer.J Oncol2014
25428177Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.BMC Pharmacol Toxicol2014
  • 1 - 29 of 29

Recommended Authors

Likhitha Kolla
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2018
Number of shared co-authors 0
Gabrielle Choonoo
Regeneron Pharmaceuticals
Career Start Year 2016
Number of shared co-authors 0
Jessica A Lavery
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 1
Kee Yuan Ngiam
Yong Loo Lin School of Medicine, National University of Singapore
Career Start Year 2013
Number of shared co-authors 0
Jennifer Y Y Kwan
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2013
Number of shared co-authors 2
Dylan Nelson
Oregon State University
Career Start Year 2011
Number of shared co-authors 0
Kyle R Covington
Baylor College of Medicine
Career Start Year 2010
Number of shared co-authors 0
Quy Nguyen
University of California irvine
Career Start Year 2009
Number of shared co-authors 0
John Pang
University of Washington
Career Start Year 2009
Number of shared co-authors 0
Farhoud Faraji
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 0
Julia Carnevale
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
James R Whittle
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 0
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 2
Elizabeth Stewart
St Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 0
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 12
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Jiang Bian
College of Medicine, University of Florida
Career Start Year 2001
Number of shared co-authors 0
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 0
Yi-Hsin Elsa Hsu
Taipei Medical University
Career Start Year 1999
Number of shared co-authors 0
Salvatore La Rosa
university of massachusetts amherst Chan Medical School
Career Start Year 1998
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Mark Lawler
Queens University Belfast Belfast
Career Start Year 1988
Number of shared co-authors 0
Joseph A Califano
University of California
Career Start Year 1977
Number of shared co-authors 0

Collaborators

John W Barrett
University of Western Ontario
Co-authored papers 17
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 17
Anthony C Nichols
University of Western Ontario
Co-authored papers 17
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 15
Joe S Mymryk
University of Western Ontario
Co-authored papers 14
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 14
Kara M Ruicci
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 12
Paul C Boutros
University of California los angeles
Co-authored papers 10
Christopher J Howlett
Western University
Co-authored papers 8
William Stecho
University of Western Ontario
Co-authored papers 8
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 8
David A Palma
University of Western Ontario
Co-authored papers 7
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 6
Farhad Ghasemi
Western University
Co-authored papers 6
Paul Plantinga
University of Western Ontario
Co-authored papers 5
Laurie Ailles
University of Toronto
Co-authored papers 5
Alessandro Datti
University of Perugia
Co-authored papers 5
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Stephenie D Prokopec
University Health Network
Co-authored papers 4
Krupal B Patel
Moffitt Cancer Center
Co-authored papers 4
Neil Mundi
Southern Illinois University School of Medicine
Co-authored papers 4
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Co-authored papers 3
Mohammad Imran Khan
King Abdulaziz University (KAU), King Abdulaziz University
Co-authored papers 3
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Co-authored papers 3
Ren X Sun
Ontario Institute for Cancer Research, University of Toronto
Co-authored papers 3
Axel Sahovaler
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 2
Hon S Leong
University of Toronto
Co-authored papers 2
Matthew R Lowerison
University of Illinois at Urbana-Champaign
Co-authored papers 2
Giananthony Rizzo
Western University
Co-authored papers 2
Sandeep Dhaliwal
University of California at Davis School of Medicine
Co-authored papers 2
Release 1.2